Despite being vaccine-preventable, hepatitis B virus (HBV) infection remains the seventh
leading cause of mortality in the world. In South Africa (SA), over 1.9 million people are …

With the highest annual fatality ratio (mortality-to-incidence ratio), reported for a human
cancer, hepatocellular carcinoma (HCC) ranks as the third leading cause of cancer-related …

Hepatitis B virus (HBV) is divided into nine genotypes, A to I. Currently, it remains unclear
how the individual genotypes contribute to the estimated 250 million chronic HBV infections …

Methods This was a cross-sectional study involving 287 pregnant women enrolled for three
months (September to December 2014) from Nairobi and neighbouring counties. A …

Hepatitis B virus (HBV), a DNA virus, replicates via an RNA intermediate, through reverse
transcription catalysed by the viral polymerase that lacks proof reading ability. Thus …

HBV testing and diagnosis of HBV-related liver disease in low-income and middle-income
countries differs substantially from that in developed countries in terms of access to …

Of 350 million people worldwide are chronically infected with hepatitis B virus (HBV) and are
at risk of developing cirrhosis and hepatocellular carcinoma (HCC) later in life. HBV is the …

Hepatitis B virus (HBV) has ten genotypes (A–J) and over 40 sub-genotypes based on the
divergence of≥ 8% and 4 to< 8% in the complete genome respectively. These genotypes …

Background Chronic Hepatitis B virus (HBV) infection causes liver cirrhosis and cancer and
is a major public health concern in Kenya. However, so far no systematic review and meta …

AIM: To analyze the hepatitis B virus (HBV) characters in China, as well as the correlation
between several HBV mutation and hepatitis symptoms. METHODS: A total of 1148 HBV …